Skip to search formSkip to main contentSkip to account menu

L 158809

Known as: L-158,809, L-158809 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Antihypertensive AgentsImidazolesTetrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys.
PURPOSE Internal irradiation of kidneys as a consequence of radioimmunotherapy, radiation accidents, or nuclear terrorism can… 
2000
2000
Angiotensin II receptor antagonist, L-158,809, prevents intimal hyperplasia in dog grafted veins.
1998
1998
Effect of the novel angiotensin II type 1 receptor antagonist L-158,809 on acute infarct expansion and acute anterior myocardial infarction in the dog.
OBJECTIVES To assess the effect of the angiotensin II type 1 receptor (AT1-R) antagonist L-158,809 on acute infarct expansion and… 
1997
1997
Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure.
Enhanced sympathetic outflow is seen in both patients with congestive heart failure and animals with experimental heart failure… 
1997
1997
Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
Highly Cited
1996
Highly Cited
1996
Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function.
To gain insight into the contribution of immunologic and hemodynamic factors in the progressive demise of structure and function… 
1996
1996
Blockade of AT1 receptors enhances baroreflex control of heart rate in conscious rabbits with heart failure.
Because the renin-angiotensin system is activated in heart failure, we hypothesized that angiotensin II (ANG II) plays a role in… 
1995
1995
Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats.
1993
1993
Angiotensin II binding sites on micro-organisms contaminating cell cultures
1993
1993
A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site.
The availability of peptide and non-peptide Ang II receptor antagonists has permitted the study of Ang II receptor heterogeneity… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)